Search

Your search keyword '"Erwin G. Van Meir"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Erwin G. Van Meir" Remove constraint Author: "Erwin G. Van Meir" Topic medicine.disease Remove constraint Topic: medicine.disease
110 results on '"Erwin G. Van Meir"'

Search Results

1. EPCO-09. LONGITUDINAL ANALYSIS OF DIFFUSE GLIOMA REVEALS CELL STATE DYNAMICS AT RECURRENCE ASSOCIATED WITH CHANGES IN GENETICS AND THE MICROENVIRONMENT

2. Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis

3. The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen

4. Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth

5. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment

6. Ten-eleven translocation protein 1 modulates medulloblastoma progression

7. CSIG-25. BAI1/ADGRB1 REGULATES TGFβ1-INDUCED MESENCHYMAL SWITCH IN MEDULLOBLASTOMA

8. The transcriptional landscape of Shh medulloblastoma

9. Subgroup and subtype‑specifc outcomes in adult medulloblastoma

10. Longitudinal molecular trajectories of diffuse glioma in adults

11. The advent of precision epigenetics for medulloblastoma

12. Two new species of betatorqueviruses identified in a human melanoma that metastasized to the brain

13. Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway

14. A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis

15. Pattern of Relapse and Treatment Response in WNT- Activated Medulloblastoma

16. Taking a HIF pill for old age diseases?

17. PDTM-12. ADGRB3 IS EPIGENETICALLY SILENCED IN WNT-MEDULLOBLASTOMA AND ITS REACTIVATION HAS THERAPEUTIC BENEFITS

18. Overcoming therapeutic resistance in glioblastoma: the way forward

19. Design and synthesis of benzopyran-based inhibitors of the hypoxia-inducible factor-1 pathway with improved water solubility

20. Neutrophils traffic in cancer nanodrugs

21. STEM-16. IGF1/N-CADHERIN/b-CATENIN/CLUSTERIN SIGNALING AXIS MEDIATES ADAPTIVE RADIORESISTANCE IN GLIOBLASTOMA

22. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

23. Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma

24. Arylsulfonamide 64B inhibits hypoxia/HIF-induced expression of c-Met and CXCR4 and reduces primary tumor growth and metastasis of uveal melanoma

25. PDTM-27. EPIGENETIC LOSS OF BAI1 EXPRESSION IN CEREBELLAR GRANULE NEURON PRECURSORS INACTIVATES THE p53 TUMOR SUPPRESSOR AND FACILITATES MEDULLOBLASTOMA FORMATION IN THE CEREBELLUM

26. CADD-26. SMALL MOLECULE EPIGENETIC TARGETING OF METHYL-CPG BINDING PROTEIN 2 (MBD2) FOR MEDULLOBLASTOMA THERAPY

27. Comprehensive Characterization of Cancer Driver Genes and Mutations

28. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

29. Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma

30. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes ineach tumor context

31. Genomic and functional approaches to understanding cancer aneuploidy

32. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

33. Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images

34. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium

35. Systematic analysis of splice-site-creating mutations in cancer

36. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas

37. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

38. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

39. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

40. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

41. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

42. Intertumoral Heterogeneity within Medulloblastoma Subgroups

43. Overexpression of MBD2 in Glioblastoma Maintains Epigenetic Silencing and Inhibits the Antiangiogenic Function of the Tumor Suppressor Gene BAI1

44. Proteomics of gliomas: Initial biomarker discovery and evolution of technology

45. A conspiracy of glioma and endothelial cells to invade the normal brain

46. ANGI-14. EPIGENETIC REACTIVATION OF BAI1 SUPPRESSES TUMOR INVASION BY PREVENTING TGFβ1-INDUCED MESENCHYMAL SWITCH IN GLIOBLASTOMA

47. Abstract B17: ADGRB3 is a novel tumor suppressor epigenetically silenced in WNT medulloblastoma

48. An Integrative Approach for In Silico Glioma Research

49. Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma

50. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer

Catalog

Books, media, physical & digital resources